AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00%

OSX Osteopore Limited

Healthcare · Medical Instruments & Supplies · website
$0.00
52wk 0.00 – 0.03
Overall
Value
Growth
Health
Quality
Momentum
Dividend
Price
About Osteopore Limited

Osteopore Limited, a regenerative medicine company, engages in the production of 3D-printed biomimetic and bioresorbable implants in Vietnam, South Korea, the Philippines, Singapore, India, Taiwan, Indonesia, the Netherlands, the United Arab Emirates, Australia, and internationally. The company commercializes products designed to enable natural bone healing across multiple therapeutic areas. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. It manufactures and trades medical implants and medical devices; and provides technology services, as well as engages in research and experimental development on biotechnology and medical science. Osteopore Limited was founded in 2003 and is headquartered in Singapore.

Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$2.77M
P/E (trailing)
P/E (forward)
EPS (trailing)
-0.02
Dividend yield
Payout ratio
0.0%
Beta
-0.02
EV / EBITDA
-0.71
Price / Book
-0.67
ROE
Operating margin
-123.1%
Net margin
-121.8%
Total cash
$656,672
Total debt
$155,305
Current ratio
0.85
Debt / Equity
Free cash flow
$-413,047
Avg volume
3.79M
Latest annual results (FY ending 31 Dec 2025)
  • Revenue$3.06M
  • Gross profit$2.37M
  • Operating income-$3.41M
  • Net income-$3.72M
  • Diluted EPS
  • Free cash flow-$2.55M
  • Net debt$2.14M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $59.53B 14.0
RMD $43.89B 20.4
SIG $34.28B 59.4
FPH $20.25B 52.2
PME $17.21B 73.5
SHL $10.79B 19.7
RHC $10.13B 34.8
COH $7.90B 22.9